Liquidity Cushion Buys Time, But Cash Burn and Revenue Conversion Remain Key Risks

What happened

D-Wave's liquidity position has strengthened to $546.2 million in cash and marketable securities as of June 30, 2026, up from prior periods and supplemented by a CHIPS OTA for up to $100 million in milestone-based funding. However, operating cash burn reached $73.5 million in the first half of 2026, and adjusted EBITDA losses have widened as operating costs surge, largely due to the Quantum Circuits acquisition and increased R&D spending. The company's $40.7 million remaining performance obligations, with 57% expected within 12 months, offer a path to revenue recognition, but first-half 2026 revenue of only $5.9 million shows the conversion is not yet happening at scale. Meanwhile, customer concentration remains high with Customer A at 35% of revenue, and QCaaS revenue of $3.6 million is still too small to offset the burn. Overall, the liquidity reduces near-term survival risk, but the stock's current valuation of $4.0 billion demands faster commercialization than the current trajectory suggests.

Implication

The news does not change our WAIT rating or conviction of 3.5. The key catalysts over the next 3-6 months are the conversion of RPO into recognized revenue and scaling of QCaaS above low-single-digit millions. If the next quarterly filing shows RPO conversion below 50% or QCaaS remains below $4 million, the bear case becomes more likely and the stock could drift toward the $7-9 range. Conversely, if system revenue rebounds and QCaaS exceeds $6 million, the bull case of $14 becomes plausible. For now, the risk-reward is balanced at current prices around $10.70, with a more attractive entry below $9.

Thesis delta

The thesis remains unchanged: D-Wave's commercialization hinges on converting backlog and production wins into reported revenue. The news article highlights liquidity and government funding, which we already accounted for, but it also underscores the rising cash burn and widening losses that make execution risk the central issue. Therefore, no change in our WAIT rating or valuation ranges, but we will monitor the next filing closely for RPO conversion rates and QCaaS trajectory.